{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T13:48:38Z","timestamp":1785332918763,"version":"3.55.0"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T00:00:00Z","timestamp":1699056000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/20\/09"],"award-info":[{"award-number":["HIPS\/20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/20\/09"],"award-info":[{"award-number":["HIPS\/20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/20\/09"],"award-info":[{"award-number":["HIPS\/20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/20\/09"],"award-info":[{"award-number":["HIPS\/20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/20\/09"],"award-info":[{"award-number":["HIPS\/20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/20\/09"],"award-info":[{"award-number":["HIPS\/20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/20\/09"],"award-info":[{"award-number":["HIPS\/20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/20\/09"],"award-info":[{"award-number":["HIPS\/20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/20\/09"],"award-info":[{"award-number":["HIPS\/20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014589","name":"Chief Scientist Office, Scottish Government Health and Social Care Directorate","doi-asserted-by":"publisher","award":["HIPS\/20\/09"],"award-info":[{"award-number":["HIPS\/20\/09"]}],"id":[{"id":"10.13039\/100014589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Health Serv Res"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>Scotland has the highest rate of drug related deaths (DRD) in Europe. These are deaths in people who use drugs such as heroin, cocaine, benzodiazepines and gabapentinoids. It is a feature of deaths in Scotland that people use combinations of drugs which increases the chance of a DRD. Many deaths involve \u2018street\u2019 benzodiazepines, especially a drug called etizolam. Many of the \u2018street\u2019 benzodiazepines are not licensed in the UK so come from illegal sources. People who use opiates can be prescribed a safer replacement medication (e.g., methadone). While guidance on management of benzodiazepines use highlights that there is little evidence to support replacement prescribing, practice and evidence are emerging.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Aim<\/jats:title>\n                <jats:p>To develop an intervention to address \u2018street\u2019 benzodiazepines use in people who also use opiates.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The MRC Framework for Complex Interventions was used to inform research design. Co-production of the intervention was achieved through three online workshops with clinicians, academics working in the area of substance use, and people with lived experience (PWLE). Each workshop was followed by a PWLE group meeting. Outputs from workshops were discussed and refined by the PWLE group and then further explored at the next workshop.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>After these six sessions, a finalised logic model for the intervention was successfully achieved that was acceptable to clinicians and PWLE. Key components of the intervention were: prescribing of diazepam; anxiety management, sleep, and pain; and harm reduction resources (locked box and a range of tips), personal safety conversations, as well as a virtual learning environment.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>A co-produced intervention was developed for next stage clinical feasibility testing.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s12913-023-10201-7","type":"journal-article","created":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T07:01:58Z","timestamp":1699081318000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Development of an intervention to manage benzodiazepine dependence and high-risk use in the context of escalating drug related deaths in Scotland: an application of the MRC framework"],"prefix":"10.1186","volume":"23","author":[{"given":"Karen","family":"Berry","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catriona","family":"Matheson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Dumbrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Parkes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Kilonzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"MacLennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trina","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,11,4]]},"reference":[{"key":"10201_CR1","unstructured":"Johnson CF, Barnsdale LR, McAuley A. Investigating the role of benzodiazepines in drug-related mortality- A systematic review undertaken on behalf of The Scottish National Forum on Drug-Related Deaths. NHS Health Scotland. 2016. Available: - (scotpho.org.uk). Accessed 5 May 23."},{"key":"10201_CR2","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. The misuse of benzodiazepines among high-risk opioid users in Europe. EMCDDA. 2018. Available: Misuse of benzos_POD2015.pdf. Accessed 5 May 23"},{"key":"10201_CR3","unstructured":"National Records of Scotland. Drug-related deaths in Scotland in 2021. Available: Drug-related deaths in Scotland in 2021, Report (nrscotland.gov.uk). 2022. Accessed 5 May 23."},{"key":"10201_CR4","unstructured":"Scottish Government. National Mission on Drug Deaths: Plan 2022\u20132026. Scotland. Available: National Mission on Drug Deaths: Plan 2022\u20132026 (www.gov.scot). 2022. Accessed 5 May 23."},{"key":"10201_CR5","volume-title":"Anxiety disorders. Qulity standard [QS53]","author":"National Institute for Health and Care Excellence - NICE","year":"2014","unstructured":"National Institute for Health and Care Excellence - NICE. Anxiety disorders. Qulity standard [QS53]. 2014. Available: Overview | Anxiety disorders | Quality standards | NICE. Accessed 5 May 23."},{"key":"10201_CR6","unstructured":"Department of Health and Social Care. Drug misuse and dependence: UK guidelines on clinical management. Available: Drug misuse and dependence: UK guidelines on clinical management - GOV.UK (www.gov.uk). 2017. Accessed 5 May 23."},{"key":"10201_CR7","unstructured":"Taylor S, Annand F, Burkinshaw P, Greaves F, Kelleher M, Knight J, Perkins C, Tran A, White M, Marsden J. Dependence and withdrawal associated with some prescribed medicines: an evidence review. Public Health England. 2019. Available: Dependence and withdrawal associated with some prescribed medicines: an evidence review (publishing.service.gov.uk). Accessed 5 May 23."},{"issue":"1","key":"10201_CR8","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1111\/j.1360-0443.2008.02364.x","volume":"104","author":"JM Parr","year":"2009","unstructured":"Parr JM, Kavanagh DJ, Cahill L, Mitchell G, Young RM. Effectiveness of current treatment approaches for benzodiazepine discontinuation: a meta-analysis. Addiction. 2009;104(1):13\u201324. https:\/\/doi.org\/10.1111\/j.1360-0443.2008.02364.x. Accessed 5 May 23.","journal-title":"Addiction"},{"key":"10201_CR9","doi-asserted-by":"crossref","unstructured":"Baandrup L, Ebdrup BH, Rasmussen J\u00d8, Lindschou J, Gluud C, Glenth\u00f8j BY.\u00a0 Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users. Cochrane Database Syst Rev, 15;3(3). Available: Pharmacological interventions for benzodiazepine discontinuation in chronic benzodiazepine users - PMC (nih.gov). 2018. Accessed 5 May 23.","DOI":"10.1002\/14651858.CD011481.pub2"},{"key":"10201_CR10","unstructured":"Matheson, C; Best, C; Cowden, F; Dumbrell, J; Schofield, J; Ritchie, T; Robertson, R; Duncan, C; Kessavalou, K; Woolston, C; Vucic, C. Assessing the safety and utility of benzodiazepines prescribing in opiate replacement therapy. Drug Deaths Task Force Research Fund Report to Scottish Government. 2022. Available by request to the lead author."},{"key":"10201_CR11","doi-asserted-by":"publisher","unstructured":"Macleod J, Steer C, Tilling K, Cornish R, Marsden J, Millar T, Strang J, Hickman M. Prescription of benzodiazepines, z-drugs, and gabapentinoids and mortality risk in people receiving opioid agonist treatment: Observational study based on the UK Clinical Practice Research Datalink and Office for National Statistics death records. PLoS Med 26;16(11). https:\/\/doi.org\/10.1371\/journal.pmed.1002965. 2019. Accessed 5 May 23.","DOI":"10.1371\/journal.pmed.1002965"},{"issue":"1","key":"10201_CR12","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1177\/0269881116675508","volume":"31","author":"A Bakker","year":"2017","unstructured":"Bakker A, Streel E. Benzodiazepine maintenance in opiate substitution treatment: good or bad? A retrospective primary care case-note review. J Psychopharmacol. 2017;31(1):62\u20136. https:\/\/doi.org\/10.1177\/0269881116675508. Accessed 5 May 23.","journal-title":"J Psychopharmacol."},{"issue":"12","key":"10201_CR13","doi-asserted-by":"publisher","first-page":"2086","DOI":"10.1111\/j.1360-0443.2011.03563.x","volume":"106","author":"M Lader","year":"2011","unstructured":"Lader M. Benzodiazepines revisited\u2014will we ever learn? Addiction. 2011;106(12):2086\u2013109. https:\/\/doi.org\/10.1111\/j.1360-0443.2011.03563.x. Accessed 5 May 23.","journal-title":"Addiction"},{"issue":"5","key":"10201_CR14","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1111\/add.13158","volume":"111","author":"S Darke","year":"2016","unstructured":"Darke S, Farrell M. Which medications are suitable for agonist drug maintenance? Addiction. 2016;111(5):767\u201374. https:\/\/doi.org\/10.1111\/add.13158. Accessed 5 May 23.","journal-title":"Addiction"},{"issue":"1","key":"10201_CR15","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1471-2296-14-191","volume":"14","author":"C Sirdifield","year":"2013","unstructured":"Sirdifield C, Anthierens S, Creupelandt H, Chipchase SY, Christiaens T, Siriwardena AN. General practitioners\u2019 experiences and perceptions of benzodiazepine prescribing: systematic review and meta-synthesis. BMC Fam Pract. 2013;14(1):1\u201313. https:\/\/doi.org\/10.1186\/1471-2296-14-191. Accessed 5 May 23.","journal-title":"BMC Fam Pract."},{"key":"10201_CR16","doi-asserted-by":"publisher","first-page":"103512","DOI":"10.1016\/j.drugpo.2021.103512","volume":"100","author":"A McAuley","year":"2022","unstructured":"McAuley A, Matheson C, Robertson JR. From the clinic to the street: the changing role of benzodiazepines in the Scottish overdose epidemic. Int J Drug Policy. 2022;100:103512. https:\/\/doi.org\/10.1016\/j.drugpo.2021.103512. Accessed 5 May 23.","journal-title":"Int J Drug Policy"},{"key":"10201_CR17","unstructured":"National Records of Scotland. Drug\u2010related deaths in Scotland in 2018. Available: Publication (nrscotland.gov.uk). 2019. Accessed 5 May 23."},{"key":"10201_CR18","unstructured":"Matheson C, Schofield J, Bloomfield H. Street Benzodiazepine Use: The Perspectives of People who Use to Inform Intervention Development. Research Report, University of Stirling. 2021. Available: \nhttp:\/\/hdl.handle.net\/1893\/35271."},{"key":"10201_CR19","unstructured":"Schofield J, Matheson C, Anderson S, Turner M, Bloomfield H. Developments in the management of benzodiazepine dependence: the views of Scottish addiction prescribers. Research Report, University of Stirling. 2021. Available: \nhttp:\/\/hdl.handle.net\/1893\/35270."},{"key":"10201_CR20","doi-asserted-by":"publisher","unstructured":"Skivington K, Matthews L, Simpson SA, Craig P, Baird J, Blazeby JM, et al. A new framework for developing and evaluating complex interventions: update of Medical Research Council guidance. BMJ, 374. https:\/\/doi.org\/10.1136\/bmj.n2061. 2021. Accessed 5 May 23.","DOI":"10.1136\/bmj.n2061"},{"issue":"1","key":"10201_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40814-019-0425-6","volume":"5","author":"A O\u2019Cathain","year":"2019","unstructured":"O\u2019Cathain A, Croot L, Sworn K, Duncan E, Rousseau N, Turner K, et al. Taxonomy of approaches to developing interventions to improve health: a systematic methods overview. Pilot Feasib Stud. 2019;5(1):1\u201327. https:\/\/doi.org\/10.1186\/s40814-019-0425-6. Accessed 5 May 23.","journal-title":"Pilot Feasib Stud"},{"key":"10201_CR22","doi-asserted-by":"publisher","first-page":"S2","DOI":"10.1016\/S0140-6736(18)32865-4","volume":"392","author":"K Skivington","year":"2018","unstructured":"Skivington K, Matthews L, Craig P, Simpson S, Moore L. Developing and evaluating complex interventions: updating Medical Research Council guidance to take account of new methodological and theoretical approaches. Lancet. 2018;392:S2. https:\/\/doi.org\/10.1016\/S0140-6736(18)32865-4. Accessed 5 May 23.","journal-title":"Lancet"},{"issue":"8","key":"10201_CR23","doi-asserted-by":"publisher","first-page":"e029954","DOI":"10.1136\/bmjopen-2019-029954","volume":"9","author":"A O'Cathain","year":"2019","unstructured":"O\u2019Cathain A, Croot L, Duncan E, Rousseau N, Sworn K, Turner KM, et al. Guidance on how to develop complex interventions to improve health and healthcare. BMJ Open. 2019;9(8):e029954 Available: e029954.full.pdf (bmj.com). Accessed 5 May 23.","journal-title":"BMJ Open"},{"issue":"2","key":"10201_CR24","doi-asserted-by":"publisher","first-page":"201","DOI":"10.1002\/jclp.20669","volume":"66","author":"DE Logan","year":"2010","unstructured":"Logan DE, Marlatt GA. Harm reduction therapy: a practice-friendly review of research. J Clin Psychol. 2010;66(2):201\u201314. https:\/\/doi.org\/10.1002\/jclp.20669. Accessed.","journal-title":"J Clin Psychol"},{"key":"10201_CR25","doi-asserted-by":"publisher","first-page":"g1687","DOI":"10.1136\/bmj.g1687","volume":"348","author":"TC Hoffmann","year":"2014","unstructured":"Hoffmann TC, Glasziou PP, Boutron I, Milne R, Perera R, Moher D, et al. Better reporting of interventions: template for intervention description and replication (TIDieR) checklist and guide. BMJ. 2014;348:g1687. https:\/\/doi.org\/10.1136\/bmj.g1687. Accessed 5 May 23.","journal-title":"BMJ"},{"key":"10201_CR26","unstructured":"European Monitoring Centre for Drugs and Drug Addiction. Action framework for developing and implementing health and social responses to drug problems. EMCDDA. Available: Action framework for developing and implementing health and social responses to drug problems | www.emcdda.europa.eu. 2021. Accessed 5 May 23."},{"issue":"9","key":"10201_CR27","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1080\/14719037.2014.930505","volume":"17","author":"WH Voorberg","year":"2015","unstructured":"Voorberg WH, Bekkers VJ, Tummers LG. A systematic review of co-creation and co-production: Embarking on the social innovation journey. Public Manag Rev. 2015;17(9):1333\u201357. https:\/\/doi.org\/10.1080\/14719037.2014.930505. Accessed 5 May 23.","journal-title":"Public Manag Rev."},{"key":"10201_CR28","first-page":"2013","volume-title":"Tools for improvement 8\u2013Co-producing services: Co-creating health","author":"M Spencer","year":"2013","unstructured":"Spencer M, Dineen R, Phillips A. Tools for improvement 8\u2013Co-producing services: Co-creating health. Cardiff: NHS Wales; 2013. p. 2013."}],"container-title":["BMC Health Services Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-10201-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12913-023-10201-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12913-023-10201-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,4]],"date-time":"2023-11-04T07:09:54Z","timestamp":1699081794000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmchealthservres.biomedcentral.com\/articles\/10.1186\/s12913-023-10201-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,11,4]]},"references-count":28,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,12]]}},"alternative-id":["10201"],"URL":"https:\/\/doi.org\/10.1186\/s12913-023-10201-7","relation":{},"ISSN":["1472-6963"],"issn-type":[{"value":"1472-6963","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,11,4]]},"assertion":[{"value":"15 May 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 October 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 November 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethical approval was granted by the University of Stirling General University Ethics Panel (GUEP). All methods were carried out in accordance with relevant guidance and regulations including GDPR. Written informed consent was obtained from all participants prior to the commencement of data collection.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1205"}}